CliniContact outlines transparent recruitment pricing, advertising spend passed through at cost, and participant-focused reporting for clinical research teams in the United States, United Kingdom and European Union.
-- UNITED STATES, November 12, 2026 — CliniContact, a clinical trial recruitment company, is highlighting its published pricing and reporting approach for research teams, sites, site networks, contract research organizations (CROs) and sponsors. Rather than measuring campaign performance solely through clicks or leads, the company reports people screened against study eligibility criteria and ready to speak with a research site.
The approach aims to make recruitment spending and enrollment progress easier to assess, particularly when delays affect clinical study schedules.
Two Recruitment Solutions
CliniContact offers two recruitment products that can operate independently or together.
Horizon converts a study protocol into a recruitment package and study-specific marketing strategy in approximately one hour, then manages digital campaigns. Pricing starts at $800 monthly for one study at one site, with advertising expenditure passed through at cost.
Bridge connects research studies with community organizations serving prospective participants. Its registry maps 512,765 organizations across 10 countries, with pricing determined by medical indication and community accessibility.
Both products include Smart Screener, which assesses prospective participants against study eligibility criteria before site contact, and Vision, CliniContact's recruitment workspace. These tools help research teams prioritize conversations with potentially eligible participants.
Supporting Studies Facing Enrollment Delays
For studies behind schedule, CliniContact provides Rescue, a fixed-term recruitment engagement focused on a defined enrollment outcome. The service is quoted at a single upfront price, allowing sponsors and research sites to understand costs before work begins.
“Research teams shouldn’t have to guess what recruitment will cost, or wait months to find out whether it is working. We publish our prices, pass the ad spend through at cost, and report on the number that matters to a site, which is people who have been checked against the criteria and are ready for a conversation,” said Sue-Ann Schmitt, Chief Operating Officer of CliniContact.
Recruitment Experience Across Research Institutions
CliniContact reports recruitment experience involving studies at institutions including Harvard Medical School, Stanford Medicine, Vanderbilt University, Rutgers University and the University of Michigan.
By emphasizing pre-qualified participants rather than advertising engagement alone, the company seeks to provide research teams with clearer measures of recruitment activity and spending.
About CliniContact
CliniContact recruits participants for clinical trials and research studies across the United States, United Kingdom and European Union. The company works with research teams, research sites, site networks, CROs and sponsors.
For more information, visit: www.clinicontact.com/pricing.
About the company: CliniContact recruits participants for clinical trials and research studies across the United States, United Kingdom and European Union.
Contact Info:
Name: Morton Meintjes
Email: Send Email
Organization: CliniContact
Website: https://www.clinicontact.com/
Release ID: 89209539
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
